| First Author | Sorensen GL | Year | 2006 |
| Journal | Am J Physiol Heart Circ Physiol | Volume | 290 |
| Issue | 6 | Pages | H2286-94 |
| PubMed ID | 16387789 | Mgi Jnum | J:111850 |
| Mgi Id | MGI:3654965 | Doi | 10.1152/ajpheart.01105.2005 |
| Citation | Sorensen GL, et al. (2006) Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 290(6):H2286-94 |
| abstractText | Surfactant protein D (SP-D) is an important innate immune defense molecule that mediates clearance of pathogens and modulates the inflammatory response. Moreover, SP-D is involved in lipid homeostasis, and pulmonary accumulation of phospholipids has previously been observed in SP-D-deficient (Spd-/-) mice. Atherogenesis involves both inflammation and lipid deposition, and we investigated the role of SP-D in the development of atherosclerosis. SP-D synthesis was localized to vascular endothelial cells. Atherosclerotic lesion areas were 5.6-fold smaller in the aortic roots in Spd-/- mice compared with wild-type C57BL/6N mice on an atherogenic diet. HDL cholesterol (HDL-C) was significantly elevated in Spd-/- mice. Treatment of Spd-/- mice with a recombinant fragment of human SP-D resulted in decreases of HDL-C (21%) as well as total cholesterol (26%), and LDL cholesterol (28%). Plasma TNF-alpha was reduced in Spd-/- mice (45% difference). SP-D was proatherogenic in the mouse model used. The effect is likely to be due to the observed disturbances of plasma lipid metabolism and alteration of the inflammatory process, which underlie the reduced susceptibility to atherosclerosis in Spd-/- mice. |
